Canadian study of health and aging: study methods and prevalence of dementia

To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over int...

Full description

Saved in:
Bibliographic Details
Published inCanadian Medical Association journal (CMAJ) Vol. 150; no. 6; pp. 899 - 913
Format Journal Article
LanguageEnglish
Published Canada CMA Impact, Inc 15.03.1994
Subjects
Online AccessGet full text
ISSN0820-3946
1488-2329

Cover

Abstract To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.
AbstractList To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.
To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.OBJECTIVETo estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.Prevalence survey.DESIGNPrevalence survey.Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.SETTINGCommunity and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.PARTICIPANTSRepresentative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.INTERVENTIONSScreening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.MAIN OUTCOME MEASURESPrevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.RESULTSThe prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.CONCLUSIONSThese Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.
OBJECTIVE: To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. DESIGN: Prevalence survey. SETTING: Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. PARTICIPANTS: Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. INTERVENTIONS: Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. MAIN OUTCOME MEASURES: Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. RESULTS: The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. CONCLUSIONS: These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.
To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8131123$$D View this record in MEDLINE/PubMed
BookMark eNpdUE1Lw0AQXaRSa_UnCMGDt8DuTLrJehCk-AUFL3peJtlNk5Ls1mxS6L831SLqXObw3rx5752zifPOnrCZSLIsBgQ1YTOeAY9RJfKMnYew4eMgpFM2zQQKAThjqyU5MjW5KPSD2Ue-jCpLTV9F5ExE69qtb49Qa_vKm_AFbDu7o8a6wh4ujG2t62u6YKclNcFeHvecvT8-vC2f49Xr08vyfhVXKFQfmzIvSZLMBfFcWJGngAkpCWg4LyUWRihSSQpKLQQkBlAKAE5JToDKSJyzu2_d7ZC31hTj844ave3qlrq99lTrv4irK732Oz12I9Mx95zdHAU6_zHY0Ou2DoVtGnLWD0GnEpVAFCPx-h9x44fOjeE08CTjC4QD6eq3nR8fx5LxE4QietU
CODEN CMAJAX
ContentType Journal Article
Copyright Copyright Canadian Medical Association Mar 15, 1994
Copyright_xml – notice: Copyright Canadian Medical Association Mar 15, 1994
DBID CGR
CUY
CVF
ECM
EIF
NPM
4T-
4U-
ASE
FPQ
K6X
K9.
NAPCQ
7X8
5PM
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Docstoc
University Readers
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
British Nursing Index
University Readers
Docstoc
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1488-2329
EndPage 913
ExternalDocumentID PMC1486712
441560681
8131123
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Canada
GeographicLocations_xml – name: Canada
GroupedDBID ---
.55
.XZ
00U
29B
2QL
2WC
354
36B
3O-
4IJ
53G
5GY
5RS
6PF
8F7
AAFWJ
AAWTL
ABIVO
ABOCM
ABPMR
ACGOD
ACIHN
ADBBV
AEAQA
AENEX
AFCHL
AFCTW
AFPKN
AHMBA
AI.
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EMB
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
INH
INR
IOF
L7B
M5~
N4W
NPM
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OVD
OVIDX
OVT
P2P
RDH
RHI
RPM
SV3
TEORI
U5U
UHU
VH1
VVN
WH7
WOQ
X6Y
X7M
YFH
YOC
ZGI
ZXP
~H1
4T-
4U-
ASE
FPQ
K6X
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-h319t-dfbfa6a6b1a0b1e1b7234a9623d00f63cd19a9472995124d2361220a4ba239d63
ISSN 0820-3946
IngestDate Thu Aug 21 17:45:29 EDT 2025
Thu Sep 04 21:59:25 EDT 2025
Mon Jun 30 06:10:03 EDT 2025
Tue Aug 05 11:36:17 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h319t-dfbfa6a6b1a0b1e1b7234a9623d00f63cd19a9472995124d2361220a4ba239d63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-2
content type line 23
PMID 8131123
PQID 204805321
PQPubID 41339
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1486712
proquest_miscellaneous_76391331
proquest_journals_204805321
pubmed_primary_8131123
PublicationCentury 1900
PublicationDate 1994-03-15
PublicationDateYYYYMMDD 1994-03-15
PublicationDate_xml – month: 03
  year: 1994
  text: 1994-03-15
  day: 15
PublicationDecade 1990
PublicationPlace Canada
PublicationPlace_xml – name: Canada
– name: Ottawa
PublicationSubtitle CMAJ
PublicationTitle Canadian Medical Association journal (CMAJ)
PublicationTitleAlternate CMAJ
PublicationYear 1994
Publisher CMA Impact, Inc
Publisher_xml – name: CMA Impact, Inc
References 3183318 - J Gerontol. 1988 Nov;43(6):S200-5
2923012 - Acta Psychiatr Scand. 1989 Feb;79(2):190-8
1952826 - Ann Neurol. 1991 Sep;30(3):381-90
2788352 - Acta Psychiatr Scand. 1989 Jun;79(6):557-63
3165596 - Acta Psychiatr Scand Suppl. 1988;338:57-63
2242109 - Psychol Med. 1990 Feb;20(1):183-93
1955260 - Int J Epidemiol. 1991 Sep;20(3):736-48
6610841 - Neurology. 1984 Jul;34(7):939-44
3776750 - Age Ageing. 1986 Sep;15(5):278-84
1615784 - Age Ageing. 1992 May;21(3):205-10
1202204 - J Psychiatr Res. 1975 Nov;12(3):189-98
1387871 - Int J Epidemiol. 1992 Aug;21(4):763-9
2771064 - Neurology. 1989 Sep;39(9):1159-65
3324647 - Acta Psychiatr Scand. 1987 Nov;76(5):465-79
2725870 - Neurology. 1989 Jun;39(6):773-6
1898500 - Am J Public Health. 1991 Jan;81(1):63-8
1853727 - Acta Psychiatr Scand. 1991 May;83(5):350-2
3611032 - J Clin Psychiatry. 1987 Aug;48(8):314-8
1419907 - Cell Growth Differ. 1992 Jul;3(7):443-50
2589085 - Acta Psychiatr Scand. 1989 Oct;80(4):303-9
3494498 - Can J Psychiatry. 1987 Mar;32(2):81-6
2337014 - Age Ageing. 1990 Mar;19(2):84-90
1745347 - Neurology. 1991 Dec;41(12):1911-4
3490741 - Acta Psychiatr Scand. 1986 Aug;74(2):144-51
2810583 - JAMA. 1989 Nov 10;262(18):2551-6
References_xml – reference: 1615784 - Age Ageing. 1992 May;21(3):205-10
– reference: 3183318 - J Gerontol. 1988 Nov;43(6):S200-5
– reference: 2725870 - Neurology. 1989 Jun;39(6):773-6
– reference: 2589085 - Acta Psychiatr Scand. 1989 Oct;80(4):303-9
– reference: 3324647 - Acta Psychiatr Scand. 1987 Nov;76(5):465-79
– reference: 2923012 - Acta Psychiatr Scand. 1989 Feb;79(2):190-8
– reference: 2771064 - Neurology. 1989 Sep;39(9):1159-65
– reference: 2337014 - Age Ageing. 1990 Mar;19(2):84-90
– reference: 1745347 - Neurology. 1991 Dec;41(12):1911-4
– reference: 1387871 - Int J Epidemiol. 1992 Aug;21(4):763-9
– reference: 1955260 - Int J Epidemiol. 1991 Sep;20(3):736-48
– reference: 3165596 - Acta Psychiatr Scand Suppl. 1988;338:57-63
– reference: 2810583 - JAMA. 1989 Nov 10;262(18):2551-6
– reference: 1898500 - Am J Public Health. 1991 Jan;81(1):63-8
– reference: 1419907 - Cell Growth Differ. 1992 Jul;3(7):443-50
– reference: 3776750 - Age Ageing. 1986 Sep;15(5):278-84
– reference: 6610841 - Neurology. 1984 Jul;34(7):939-44
– reference: 2788352 - Acta Psychiatr Scand. 1989 Jun;79(6):557-63
– reference: 3490741 - Acta Psychiatr Scand. 1986 Aug;74(2):144-51
– reference: 1202204 - J Psychiatr Res. 1975 Nov;12(3):189-98
– reference: 1952826 - Ann Neurol. 1991 Sep;30(3):381-90
– reference: 3494498 - Can J Psychiatry. 1987 Mar;32(2):81-6
– reference: 3611032 - J Clin Psychiatry. 1987 Aug;48(8):314-8
– reference: 2242109 - Psychol Med. 1990 Feb;20(1):183-93
– reference: 1853727 - Acta Psychiatr Scand. 1991 May;83(5):350-2
SSID ssj0000327
Score 2.0540574
Snippet To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional...
To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional...
To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.OBJECTIVETo estimate the prevalence of dementia and its...
OBJECTIVE: To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. DESIGN: Prevalence survey. SETTING:...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 899
SubjectTerms Age Distribution
Aged
Aged, 80 and over
Aging
Canada - epidemiology
Caregivers
Cost of Illness
Databases, Factual
Dementia
Dementia - classification
Dementia - diagnosis
Dementia - epidemiology
Dementia - prevention & control
Female
Health aspects
Health Services Needs and Demand
Health Surveys
Humans
Logistic Models
Male
Mass Screening - methods
Mental Status Schedule
Older people
Prevalence
Research Design
Residence Characteristics
Risk Factors
Sampling Studies
Sex Distribution
Title Canadian study of health and aging: study methods and prevalence of dementia
URI https://www.ncbi.nlm.nih.gov/pubmed/8131123
https://www.proquest.com/docview/204805321
https://www.proquest.com/docview/76391331
https://pubmed.ncbi.nlm.nih.gov/PMC1486712
Volume 150
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: DIK
  dateStart: 19110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: Open access medical journals (GFMER)
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: GX1
  dateStart: 19110101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVFQY
  databaseName: Open access medical journals (GFMER)
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: RPM
  dateStart: 19850901
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: RPM
  dateStart: 19850101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b8IwELYKQ9Wl6guV0keGqluqODYh6YYqKoSALiCxRXbsFJZACyz99T2_AlRIfSxRlEscdJ99OWx_3yF0LynJoNtSHz7fLZ9yImDMYe4L2YxFFpM81LKLg2HUHdPepDnZqPlpdsmKP2afe3kl_0EVrgGuiiX7B2TLRuECnAO-cASE4fgrjEtpgaWThja0RqPA-ma5zMZoSkUvnTAA_Aw9puEZoWcIZ2w7Ty1bdgs5WzCWahNqAXjQ7rnJBGHJdFRtnjLsSRdiFH86sZOALh4aJVgL_HZ0i00to13V6uFr-jLu99NRZzJ6WLz7qqCXWvi21U0qqAIhRbGwJ5u9NwExtXTd6_el9993qW599kcn6Njm617bOP8UHcjiDB0O7I6Ec9R3nvK0m7157hkMPHC0pzF4siaLgDZsEFBPOAQu0PilM3ru-rZChT-F0LXyRc5zFrGIYxZwLDFvhYSyBFJKEQR5RDKBE5ZQ-AMDiWxIhVK6CcOAUc5CkoiI1FC1mBfyEnlJHvE4DwKGZQZNCE5iEUgWS8GZpK24jhrORamFeZkq1WVV2gPX0V1phfigFn1YIefrZQoDMcGEwB014850YWRM0lgpLYWkjlo7fi7tSnh811LMplqAHCuZRhxe_fjSBjradLtrVF19rOUNJHErfqs7xBcMPFF5
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Canadian+study+of+health+and+aging%3A+study+methods+and+prevalence+of+dementia&rft.jtitle=Canadian+Medical+Association+journal+%28CMAJ%29&rft.date=1994-03-15&rft.issn=0820-3946&rft.volume=150&rft.issue=6&rft.spage=899&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0820-3946&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0820-3946&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0820-3946&client=summon